Disease Progression  >>  goserelin acetate  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
NCT01242748 / 2010-021434-55: A Degarelix Trial in Patients With Prostate Cancer

Terminated
3
288
US, Canada, Europe, RoW
Degarelix, Firmagon, FE200486, Goserelin acetate, Zoladex
Ferring Pharmaceuticals
Prostate Cancer
12/11
01/12
NCT01073865: Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer

Completed
3
222
Japan, RoW
ZD9393 (Zoladex) 10.8 mg, Zoladex, ZD9393 (Zoladex) 3.6 mg
AstraZeneca
Breast Cancer
09/12
11/17

Download Options